Abstract. The primary function of white adipose tissues is to store excess energy. The current study aimed to investigate the roles of Gremlin 2 (Grem2), a glycoprotein in adipogenesis. Using polymerase chain reaction-based microarrays, it was determined that Grem2 was markedly downregulated in adipose tissues from obese animals and humans. In addition, 3T3-L1 cells were used to investigate the details of the mechanisms underlying the anti-adipogenic effects of Grem2. Grem2 expression was markedly decreased upon the induction of adipocyte differentiation, as demonstrated by reverse transcription-quantitative polymerase chain reaction and western blot analysis. Notably, Grem2 overexpression inhibited adipogenesis, while knockdown of Grem2 led to an increase in adipogenesis. At the molecular level, Grem2 promotes nuclear translocation of β-catenin, an integral Wnt signaling component. Consistently, inhibition of Wnt/β-catenin signaling using a retrovirus targeting the β-catenin coding region attenuated the anti-adipogenic effects of Grem2. Therefore, to the best of our knowledge, the current study shows for the first time that Grem2 may be an important regulator of adipocyte differentiation.
Introduction
When dietary nutrient intake chronically exceeds energy expenditure, obesity occurs due to an increase in the size and/or number of white adipocytes (1) . Obesity is closely associated with type 2 diabetes, fatty liver, hyperlipidemia, cardiovascular diseases and tumorigenesis (2, 3) . Thus, investigating the molecular and cellular mechanisms regulating adipocyte differentiation is crucial for designing potential therapies to prevent obesity and the associated diseases.
Decades of studies have identified a number of transcription factors involved in adipocyte differentiation, including peroxisome proliferator-activated receptor γ (PPARγ) and members of the C/EBP family (4, 5) . Additionally, a number of other factors or signaling molecules are involved in the control of adipocyte differentiation, such as Wnt/β-catenin, cAMP/CREB, and the family of kruppel-like factor (KLF) proteins (6) (7) (8) . Furthermore, recent studies have indicated that modification of these proteins has an important role in adipogenesis. It has been shown that phosphorylation, acetylation and small ubiquitin-like modifier (SUMO)ylation of PPARγ affects adipocyte differentiation, though regulation of its transcriptional activity (9) (10) (11) . In this regard, the process of adipogenesis is rather complex, suggesting that identification of the additional factors may provide novel insights into the mechanisms regulating the initiation of fat cell differentiation and obesity.
In the present study, polymerase chain reaction (PCR)-based microarrays were performed in obese and lean mice to screen potential genes involved in adipogenesis.
Materials and methods
Mice. Male C57BL/6, ob/ob and db/db mice, aged 10-12 weeks, were purchased from the Shanghai Laboratory Animal Company (Shanghai, China). All mice were housed and bred according to international standard conditions, with a 12-h dark/light cycle. For induction of obesity, mice aged 10 weeks were placed on a high-fat-diet (50 kcal% fat, 25 kcal% protein and 25 kcal% carbohydrate) for 12 weeks. The normal diet consisted of 10 kcal% fat, 15 kcal% protein and 75 kcal% carbohydrate. The animal protocol was reviewed and approved by the Animal Care Committee of Chongqing Ninth People's Hospital (Chongqing, China).
Human tissue samples. Human subcutaneous fat tissues from obese (BMI>25; n=25) and lean (BMI<23; n=20) adults were collected at the Department of Endocrinology at Chongqing Ninth People's Hospital. All subjects had a stable weight, defined as the absence of fluctuations of >1% of body weight for at least 2 months prior to surgery. Adipose tissue was 
Results

Downregulation of Grem2 in obese mice and humans.
To identify potential genes involved in adipogenesis and obesity, male C57BL/6 mice aged 10 weeks were placed on high-fat or normal diets for 12 weeks. The mice were sacrificed by cervical dislocation and gene expression arrays were performed using epididymal adipose tissues. The clustering analysis of the Affymetrix arrays revealed that 1,174 genes were upregulated and 1,572 genes were downregulated in the adipose tissues of mice fed a high-fat-diet compared with those fed a normal diet (P<0.05; data not shown). Among these genes, it was determined that Grem2 was significantly downregulated (P<0.001).
Its downregulation was further confirmed by RT-qPCR and western blot analysis (Fig. 1A and B) .
To determine whether the inhibition of Grem2 represents a common feature of obesity, db/db and ob/ob mice were employed as models for monogenic-induced obesity. Indeed, Grem2 mRNA and protein levels were found to be reduced in the epididymal adipose tissues of these mice, as compared with lean controls (Fig. 1C-F) . Notably, Grem2 mRNA and protein levels were significantly reduced in subcutaneous fat from obese humans ( Fig. 1G and H) , further suggesting that the downregulation of Grem2 expression may be a conserved feature in obese mice and humans.
Grem2 suppresses the differentiation of 3T3-L1 preadipocytes into adipocytes.
To explore the functions of Grem2 in adipogenesis, its gene expression was investigated at numerous time points during 3T3-L1 differentiation. The RT-qPCR results revealed that Grem2 mRNA gradually reduced from day 0 post-induction ( Fig. 2A) . The protein levels for Grem2 were consistent with its mRNA levels (Fig. 2B) .
The role of Grem2 in adipogenesis was tested using retroviruses carrying Grem2 cDNA or empty vector, which resulted in forced overexpression of Grem2 in 3T3-L1 preadipocytes (Fig. 3A) . These cells were cultured to confluence and differentiated using the standard induction cocktail for 8 days. Cell morphology indicated that cells overexpressing Grem2 accumulated significantly less lipids than the control cells (Fig. 3B) . In addition, the expression levels of adipogenic regulators such as C/EBPα and PPARγ were reduced ( Fig. 3C and D) , which was consistent with the Oil Red O staining. Furthermore, markers of mature adipocytes LPL, PEPCK, CD36 and aP2, which are downstream targets of C/ EBPα and PPARγ, were repressed by Grem2 overexpression (Fig. 3E) .
Grem2 knockdown promotes adipocyte differentiation.
To further examine the roles of Grem2, its specific siRNA was transfected into 3T3-L1 cells (Fig. 4A) . As a result, knockdown of Grem2 levels showed a clear increase in the adipogenic potential of the 3T3-L1 cells compared with that of the cells treated with the negative control siRNA, as illustrated by cell morphology (Fig. 4B) . Furthermore, knockdown of Grem2 increased expression levels of the adipocyte markers including C/EBPα, PPARγ, LPL, PEPCK, CD36 and aP2 ( Fig. 4C and D) . Together, these results indicate that Grem2 is a critical negative regulator in the adipogenesis. 
Grem2 activates Wnt/β-catenin signaling in adipocytes.
Finally, the molecular basis for the observed phenotypic changes in 3T3-L1 cells with Grem2 overexpression was investigated. As shown in Fig. 5A , Wnt signaling was highly activated by Grem2 overexpression, as evidenced by nuclear accumulation of β-catenin, while other signaling molecules, including p38, AKT and cAMP/CREB, remained unaffected (Fig. 5B) . Subsequently, it was investigated whether ablation of β-catenin reversed the roles of Grem2. A retrovirus targeting a β-catenin coding region (sh-catenin) was generated using pAD_BLOCK_IT_DEST vectors (Invitrogen Life Technologies, Grand Island, NY, USA) to knockdown endogenous β-catenin expression in 3T3-L1 cells (Fig. 5C) . As a result, sh-catenin largely attenuated the inhibitory roles of Grem2 on the adipogenesis, as evidenced by gene expression of adipogenic markers (Fig. 5D) , suggesting that the role of Grem2 in the adipogenesis, at least in part, relies on Wnt/β-catenin activation.
Discussion
In the present study, it was determined that the Grem2 gene was significantly downregulated in white adipose tissue from obese mice and humans. Using 3T3-L1 cells cultured in vitro, it was demonstrated that Grem2 inhibited adipocyte differentiation. Thus, for the first time to the best of our knowledge, these results identify Grem2 as a key regulator in adipose formation and obesity. Members of the Gremlin family, including Grem2, have been shown to be bone morphogenetic protein (BMP) antagonists (12) . Indeed, Grem2 regulates BMP signaling in cardiomyocyte and osteoblast differentiation (13, 14) . Furthermore, a recent human study revealed that genetic variants in Grem2 are associated with bone mineral density (15) . Since certain members of the family of BMPs support white and brown adipocyte differentiation (16, 17) , whether Grem2 regulates BMP-induced adipogenesis requires further investigation. 
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At the molecular level, it was revealed that Grem2 activates Wnt/β-catenin signaling, as evidenced by its nuclear accumulation. Initial studies have demonstrated that ectopic expression of Wnt1, an activator of Wnt/β-catenin signaling, may inhibit adipogenesis (6,18,19) . Concurrently, pharmacological compounds that activate Wnt/β-catenin signaling or transfection of stable β-catenin block preadipocyte differentiation (18) . However, inhibition of Wnt signaling promotes cell differentiation (18, 20) , indicating that Wnt signaling has a negative role in the adipocyte differentiation. In accordance with this conclusion in vitro, transgenic mice overexpressing Wnt10b, an endogenous factor for Wnt signaling, have a 50% reduction in adiposity under a normal chow diet (21) . These mice resist expansion of adipose tissue under conditions of high-fat-diet-induced and genetic-induced obesity (21) . Furthermore, recent genetic research indicated the importance of Wnt/β-catenin signaling in human obesity. Polymorphisms of the Wnt10b gene may be associated with obesity in human subjects of European origin (22) . Together, these data suggest that modulators of Wnt/β-catenin pathway may represent a useful therapeutic target for obesity (23) .
In conclusion, the results of the current study highlight a pivotal role for Grem2 in white fat-cell differentiation by controlling Wnt/β-catenin signaling. Further studies are 
